Skip to main content
Fig. 1 | Substance Abuse Treatment, Prevention, and Policy

Fig. 1

From: Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway

Fig. 1

Proportion of individuals reporting problems by EQ-5D-5L domain; overall, by age, gender and OAT medication. OAT = opioid agonist therapy. Altogether 609 respondents, 8 patients missed values on one dimension. 11 patients, which did not receive either methadone or buprenorphine-based medications are left out of the illustration but not analysis. Proportions (%) and dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression). 1A: Overall, 1B: Gender 1C: OAT medication 1D: Age groups

Back to article page